Conatus Pharmaceuticals (CNAT) - NASDAQ
From other sites
Company Description
Conatus Pharmaceuticals, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel medicines to treat liver diseases. It develops lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute... More
Sector: Healthcare
Industry: Biotechnology
Country: United States